# Awiqli

NDC: 0169-3105
Generic name: Insulin icodec-abae
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260326

FDA application: BLA761326

## Active ingredients

- INSULIN ICODEC: 700 U/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-3105"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-3105
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5162b93e-5775-4581-a5e9-e8783ae0acd7